TNFRSF8 anticorps (FITC)

N° du produit ABIN536664

Détail du produit anti-TNFRSF8 anticorps (FITC)

Antigène: TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp TNFRSF8 est conjugé à/à la FITC

Application: Flow Cytometry (FACS)

Fonction: Mouse monoclonal antibody raised against TNFRSF8.

Specificité: This antibody recognizes extracellular part of CD30 (Ki-1 antigen), a 105 KDa single chain glycoprotein expressed on Hodgkin's and Reed-Sternberg cells.

Réactivité croisée: Humain

Immunogène: Expression vector containing CD30 cDNA (booster suspension of THP-1 cell line).

Clone: MEM-268

Isotype: IgG

Information d'application

Indications d'application: Flow Cytometry (20 µL in human blood cells 100 µL in whole blood or 10⁶ cells in a suspension)
The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In PBS (0.2 % BSA, 0.09 % sodium azide)

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Store in the dark at 4°C. Do not freeze.
Avoid prolonged exposure to light.
Aliquot to avoid repeated freezing and thawing.

Références pour anticorps anti-TNFRSF8 (FITC) (ABIN536664)

Kusanovic, Romero, Hassan, Gotsch, Edwin, Chaiworapongsa, Erez, Mittal, Mazaki-Tovi, Soto, Than, Friel, Yoon, Espinoza: "Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies." dans: The journal of maternal-fetal & neonatal medicine, Vol. 20, Issue 12, pp. 867-78, (2008) (PubMed).

Wright, Rumble, Duckett: "CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells." dans: The Journal of biological chemistry, Vol. 282, Issue 14, pp. 10252-62, (2007) (PubMed).

Zeiser, Nguyen, Hou, Beilhack, Zambricki, Buess, Contag, Negrin: "Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease." dans: Blood, Vol. 109, Issue 5, pp. 2225-33, (2007) (PubMed).

Détails sur TNFRSF8

Antigène: TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))

Autre désignation: CD30 (TNFRSF8 Produits)

Synonymes: anticorps CD30, anticorps D1S166E, anticorps Ki-1, anticorps Cd30, anticorps Ki, anticorps TNFRSF8, anticorps TNF receptor superfamily member 8, anticorps tumor necrosis factor receptor superfamily, member 8, anticorps TNFRSF8, anticorps Tnfrsf8

ID gène: 943